Klaus Edvardsen
Corporate Officer/Principal at NYKODE THERAPEUTICS
Profile
Klaus Edvardsen is currently the Chief Development Officer at Nykode Therapeutics ASA since 2022.
Prior to this, he was the Chief Development Officer at CureVac NV from 2021 to 2022.
He also served as the SVP& Head-Global Medicines Development Oncology at AstraZeneca PLC.
Dr. Edvardsen holds a doctorate degree from the University of Copenhagen.
Klaus Edvardsen active positions
| Companies | Position | Start |
|---|---|---|
| NYKODE THERAPEUTICS | Corporate Officer/Principal | 01/07/2022 |
Former positions of Klaus Edvardsen
| Companies | Position | End |
|---|---|---|
| CUREVAC N.V. | Corporate Officer/Principal | 30/06/2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Training of Klaus Edvardsen
| University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| CUREVAC N.V. | Health Technology |
| NYKODE THERAPEUTICS | Health Technology |
- Stock Market
- Insiders
- Klaus Edvardsen
